BioSpace News Archive

AirXpanders, Inc. announced that the Company has retained Cowen as an independent financial advisor to assist in exploring financial and strategic alternatives.

10-story facility integrates outpatient services with nearby hospital care

The first generic version of Penicillamine Capsules USP is now approved in the U.S.

Company scales direct-to-consumer at-home testing diagnostics and personal health services; expands platform development and supply logistics in the U.S.

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported first quarter 2019 financial results and recent business highlights.

Tivity Health, Inc. (NASDAQ:TVTY) today announced financial results for the first quarter ended March 31, 2019.

Heron Therapeutics, Inc. announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, at 11:35 a.m. PDT at the Encore Hotel in Las Vegas, NV.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three months ended March 31, 2019 and provides an update on its business progress.

Tetraphase Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2019, provided an overview of recent achievements, and highlighted key milestones for 2019.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced financial results for the quarter ended March 31, 2019